

















Recent	 initiatives	 in	drug	discovery	have	 focussed	on	 the	development	of	 synthetic	methodologies	 to	
low	 molecular	 weight,	 lead-like,	 sp3-atom	 rich	 molecules;	 that	 have	 the	 potential	 for	 diverse	



























Oxetanes	 can	 be	 prepared	 using	 a	 variety	 of	methods	 including	 the	 intramolecular	Williamson	 ether	








We	 foresaw	 that	 the	 2-carboxyl-1-oxa-7-azaspiro[3,5]nonane	 scaffold	 5	 should	 be	 accessible	 by	 the	
aforementioned	 gold	 catalysed	 rearrangement	 of	 a	 propargylic	 alcohol	 (Figure	 4),	 	 provided	 that	 the	





































Entrya	 Time	/	h	 Temp	/	°C	 iPrAuNTf2	/	mol%	 	SM	7	/	%a	 	Product	8	/%a	
1	 20	 40	 5	 37	 58	
2	 20	 40	 20	 27	 62	
3	 20	 60	 5	 7	 74	
4b	 72	 60	 5	 0	 0	













Scheme	 2	 Initial	 attempts	 at	 diversification	 of	 1-oxa-7-azaspiro[3,5]nonane	 core	 8.	 	 Reagents	 and	
conditions	a)	MeI,	Cs2CO3,	DMF,	87%	(mass	recovery).	B)	BnNH2,	Na(OAc)3BH,	1,2-DCE,	35%.	
Reduction	of	the	ketone	was	more	successful	and	the	syn	diastereomer	of	alcohol	11	was	obtained	with	
an	excellent	diastereoselectivity	 (>20:1	by	 1H	NMR	spectroscopy)	using	 sodium	 triacetoxyborohydride	











amine	 and	 DABAL-Me3	 (Scheme	 4).23	 In	 this	 way,	 benzyl	 amide	 13	 and	 isopropyl	 amide	 14	 were	



















Scheme	 5	 Library	 compounds	 synthesised	 by	 high-throughput	 methods.	 Reagents	 and	 conditions:	 a)	
carboxylic	 acid,	 i-Pr2NEt,	HATU,	DMF,	 18	 h,	 rt.;	 b)	 aldehyde,	 AcOH,	NMe4(OAc)3BH,	DMF,	 18	 h,	 rt.;	 c)	
sulfonyl	chloride,	pyridine,	DMF,	18	h,	rt.			




full	 library	 of	 419	 compounds	 was	 prepared.	 The	 design	 of	 the	 library	 was	 chosen	 to	 consider	 the	
molecular	 properties	 of	 the	 compounds,	 including	 logΡ	 and	 molecular	 weight	 and	 to	 avoid	 any	
potentially	 undesirable	 groups.	 The	 molecular	 weights	 of	 the	 compounds	 within	 the	 library	 were	
between	324	and	445	Da	(Figure	5).	The	molecular	weight	of	the	core	unfunctionalised	scaffold	is	202.	
When	 compared	 to	 two	 commercial	 libraries;	Maybridge	HitCreator	 and	Maybridge	HitFinder	we	 can	
see	that	 the	oxetane	 library	 is	more	densely	clustered	 in	 lead-like	space	compared	to	the	commercial	












Library	 Mean	MW	(Da)	 Mean	cLogP	 Mean	Fsp3	
Oxetane	Library	 399.40	 0.89	 57%	
Maybridge	HitFinder	 325.56	 3.30	 23%	
Maybridge	HitCreator	 340.17	 2.87	 30%	
Table	3:	Comparison	of	key	molecular	properties	for	the	oxetane	library	and	two	commercial	libraries.	
	






































We	utilised	 the	 library	modelling	 tool	 LLAMA	to	generate	a	principle	moment	of	 inertia	plot	of	 shape	
distribution	for	a	virtual	library	of	compounds	(see	ESI	for	full	details),	and	the	synthesised	compounds	
17a-h	 and	 18a-e	 (Figure	 7).25	 The	 virtual	 library	 of	 molecules,	 along	 with	 the	 synthesised	 examples,	
occupy	the	rod-like	area	of	molecular	space;	reflecting	the	overriding	contribution	of	the	core	scaffold	





undertaken	 on	 a	 decagram	 scale	 to	 generate	 the	 oxetan-3-one	 intermediate	 with	 three	 points	 of	
functionalisation.	 The	 scaffold	 can	 be	 further	 elaborated	 to	 prepare	 compound	 libraries	 that	 are	 of	












A	 solution	 of	 ethyl	 propiolate	 (14.8	 mL,	 145.9	 mmol)	 in	 THF	 (120	 mL)	 was	 cooled	 to	 -70	 °C	 in	 an	
acetone/dry	 ice	 bath.	 To	 this	 was	 added	 n-butyllithium	 (2.25	 M	 in	 hexanes,	 57	 mL,	 128.2	 mmol),	
dropwise	over	1	h	and	the	solution	was	stirred	at	-70	°C	for	15	min.	After	this	time,	a	solution	of	1-Cbz-4-
piperidone	6	(10.0	g,	42.9	mmol)	in	THF	(120	mL)	was	added	dropwise	over	an	hour,	ensuring	that	the	
temperature	 did	 not	 rise	 above	 -70	 °C.	 The	 resultant	 solution	was	 stirred	 at	 -70	 °C	 for	 2	 h	 until	 the	
disappearance	of	the	starting	material	was	observed	by	TLC	(50%	ethyl	acetate	in	light	petroleum).	The	
reaction	was	quenched	at	 -70	 °C	by	 the	dropwise	addition	of	a	aqueous	ammonium	chloride	solution	
(saturated,	100	mL)	over	20	min.	The	reaction	mixture	was	warmed	to	room	temperature	extracted	with	
ethyl	acetate	(4	×	100	mL).	The	combined	organic	phases	were	washed	with	brine	(2	×	100	mL),	dried	
(MgSO4)	 and	 the	 solvent	 removed	 in	 vacuo	 to	 give	 a	 brown	 oil	 (21.2	 g).	 Purification	 by	 column	
chromatography	(40%	ethyl	acetate	in	light	petroleum)	gave	the	title	compound	7	as	a	yellow	crystalline	
solid	(10.42	g,	73%):	Rf	0.47	(40%	ethyl	acetate	in	light	petroleum,	weakly	UV	active,	KMnO4	active);	mp	
92-94	 °C;	HRMS	m/z	 (ESI+)	 calcd.	 for	C18H22NO5	 [M+H]+	 requires	332.1492,	 found	332.1498,	 calcd.	 for	
C18H21NNaO5	 [M+Na]+	 requires	 354.1312,	 found	 354.1319;	 νmax	 (ATR)/cm-1	 3388,	 2227,	 1707,	 1673,	

























A	 solution	 of	 the	 ketone	 8	 (52	mg,	 0.15	mmol)	 in	 dry	 dichloroethane	 (3.3	 mL)	 was	 prepared	 under	
nitrogen.	To	this	was	added	benzylamine	(24	mg,	25	μL,	0.22	mmol)	followed	by	glacial	acetic	acid	(20	
μL,	0.35	mmol)	and	the	reaction	mixture	was	stirred	at	room	temperature	for	2	h.	After	this	time	sodium	
triacetoxyborohydride	 (64	 mg,	 0.30	 mmol)	 was	 added.	 The	 suspension	 was	 then	 stirred	 at	 room	
13	
	
temperature	 for	an	additional	18	h	until	 the	disappearance	of	 the	starting	material	was	confirmed	by	
TLC	(50%	ethyl	acetate	in	light	petroleum).	The	reaction	was	quenched	by	the	addition	of	water	(5	mL)	
and	stirred	for	1	h.	The	reaction	was	extracted	with	dichloromethane	(3	×	5	mL)	and	the	organic	phases	
were	 combined,	 dried	 (MgSO4)	 and	 the	 solvent	 removed	 in	 vacuo.	 Purification	 by	 column	
chromatography	(50%	ethyl	acetate	in	light	petroleum	to	100%	ethyl	acetate)	gave	the	title	compound	

































Silver(II)	 oxide	 (660	mg)	was	 added	 to	 a	 solution	 of	 alcohol	 11	 in	 iodomethane	 (12.2	 g,	 5.3	mL,	 86.0	
mmol).	The	reaction	mixture	was	stirred	at	45	°C	for	48	h.	Following	this	time,	the	reaction	mixture	was	
cooled	to	room	temperature	and	filtered	under	vaccum,	the	filtrate	was	washed	with	dichloromethane	
(3	 ×	 10	mL).	 The	 solvent	 was	 removed	 in	 vacuo.	 Purification	 by	 column	 chromatography	 (50%	 ethyl	
acetate	in	light	petroleum)	to	give	the	title	compound	12	as	a	colourless	oil	(150	mg,	72%).	Rf	0.60	(50%	

















ether	 (3	×	10	mL).	 The	 solvent	was	 removed	 in	 vacuo.	 Purification	by	 column	chromatography	 (100%	
ethyl	 acetate)	 to	 give	 the	 title	 compound	 13	 as	 a	 colourless	 oil	 (160	mg,	 71%).	 Rf	 0.41	 (100%	 ethyl	
acetate,	 weakly	 UV	 active,	 KMnO4	 active);	 HRMS	 m/z	 (ESI+)	 calcd.	 for	 C23H27N2O5	 [M+H]+	 requires	













iso-Propylamine	 (74	 µL,	 0.86	 mmol)	 was	 added	 to	 a	 suspension	 of	 DABAL-Me3		
(220	mg,	0.86	mmol)	in	dry	THF	(4.6	mL)	under	nitrogen	in	a	Schlenk	flask.	The	flask	was	sealed	and	the	
reaction	mixture	was	stirred	at	40	°C	for	1	h.	After	this	 time,	a	solution	of	 the	ester	11	 (200	mg,	0.57	
mmol)	 in	 dry	 THF	 (2	 mL)	 was	 added	 and	 the	 reaction	 mixture	 was	 stirred	 at	 65	 °C	 for	 20	 h.	 The	
disappearance	 of	 the	 starting	 material	 was	 observed	 by	 TLC	 (100%	 ethyl	 acetate)	 and	 the	 reaction	
mixture	was	cooled	to	room	temperature.	Aqueous	ammonium	chloride	solution	(saturated,	10	mL)	was	
added	 and	 the	 product	 was	 extracted	 with	 ether	 (3	 ×	 10	 mL).	 The	 solvent	 was	 removed	 in	 vacuo.	













Palladium	 on	 carbon	 (10%,	 44	 mg)	 was	 added	 to	 a	 solution	 of	 amide	 12	 (440	 mg,	 1.07	 mmol)	 in	
trifluoroethanol	(20	mL).	The	flask	was	evacuated	and	a	balloon	of	hydrogen	introduced.	The	suspension	
was	 then	 stirred	 at	 room	 temperature	 for	 26	 h.	 After	 this	 time,	 the	 disappearance	 of	 the	 starting	
material	 was	 observed	 by	 TLC.	 The	 reaction	 mixture	 was	 filtered	 through	 Celite	 and	 extracted	 with	
dichloromethane	 (3	 ×	 10	mL).	 The	 solvent	was	 removed	 in	 vacuo	 to	 give	 the	 title	 compound	15	as	 a	
white	 crystalline	 solid	 (291	 mg,	 99%):	mp	 69-70	 °C;	 HRMS	m/z	 (ESI+)	 calcd.	 for	 C15H21N2O3	 [M+H]+	











Palladium	 on	 carbon	 (10%,	 58	 mg)	 was	 added	 to	 a	 solution	 of	 amide	 13	 (580	 mg,	 1.60	 mmol)	 in	
trifluoroethanol	(20	mL).	The	flask	was	evacuated	and	a	balloon	of	hydrogen	introduced.	The	suspension	
was	 then	 stirred	 at	 room	 temperature	 for	 24	 h.	 After	 this	 time,	 the	 disappearance	 of	 the	 starting	
material	 was	 observed	 by	 TLC.	 The	 reaction	 mixture	 was	 filtered	 through	 Celite	 and	 extracted	 with	
dichloromethane	 (3	 ×	 10	mL).	 The	 solvent	was	 removed	 in	 vacuo	 to	 give	 the	 title	 compound	16	as	 a	
yellow	oily	solid	(358	mg,	98%).	HRMS	m/z	(ESI+)	calcd.	for	C11H21N2O3	[M+H]+	requires	229.1547,	found	











The	 research	 leading	 to	 these	 results	 was	 done	 within	 the	 European	 Lead	 Factory	 and	 has	 received	
support	 from	 the	 Innovative	Medicines	 Initiative	 Joint	Undertaking	under	 grant	 agreement	n°115489,	





Electronic	 Supplementary	 Information	 (ESI)	 available:	 experimental	 details	 for	 library	 generation,	
copies	of	1H	and	13C	NMR	spectra.	See	DOI:	xxxxxxxx	
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